G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	143.92	78.41	152.59	139.68	114.75	12.28
Short-Term Investments	281.9	351.9	256.29	173.24	91.2	96.6
Cash & Short-Term Investments	425.82	430.31	408.87	312.92	205.95	108.88
Cash Growth	-6.05%	5.24%	30.66%	51.94%	89.15%	-9.31%
Accounts Receivable	13.82	17.06	17.8	14.78	0.75	5.09
Other Receivables	0.19	0.24	0.16	0.15	0.02	0.03
Receivables	14.01	17.31	17.96	14.93	0.77	5.12
Inventory	26.4	25.3	21.71	22.9	24.64	19.83
Prepaid Expenses	6.03	1.78	2.38	1.41	1.32	2.07
Total Current Assets	472.26	474.69	450.92	352.17	232.69	135.9
Property, Plant & Equipment	363.48	366.04	372.31	375.12	375.15	382.85
Other Intangible Assets	132.44	132.73	133.33	133.89	134.68	135.51
Long-Term Deferred Tax Assets	7.9	0.35	0.26	19.65	37.95	37.59
Other Long-Term Assets	1.27	1.42	2.37	2.27	2.31	0.28
Total Assets	977.35	975.22	959.17	883.1	782.78	692.13

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.34	7.53	8.34	4.03	8.97	2.73
Accrued Expenses	-	15.48	17.72	17.34	8.11	1.64
Current Portion of Leases	0.42	0.78	0.88	0.69	-	-
Current Income Taxes Payable	1.71	15.62	3.1	-	-	-
Current Unearned Revenue	0.38	0.13	85.23	95.24	71.85	0.45
Other Current Liabilities	92.86	7.52	9.51	1.28	2.82	3.85
Total Current Liabilities	100.72	47.05	124.77	118.57	91.74	8.68
Long-Term Leases	-	0.09	0.87	1.29	-	-
Long-Term Deferred Tax Liabilities	0.09	-	-	-	0.2	-
Total Liabilities	100.81	47.15	125.64	119.86	91.94	8.68

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	637.2	637.2	590	556.6	556.6	556.6
Additional Paid-In Capital	134.24	134.24	134.24	134.24	273.33	273.33
Retained Earnings	105.11	156.64	109.3	72.4	-139.09	-146.47
Shareholders' Equity	876.54	928.07	833.53	763.24	690.84	683.45
Total Liabilities & Equity	977.35	975.22	959.17	883.1	782.78	692.13

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.42	0.87	1.75	1.98	-	-
Net Cash (Debt)	425.4	429.44	407.13	310.94	205.95	108.88
Net Cash Growth	-5.87%	5.48%	30.93%	50.98%	89.15%	-9.31%
Net Cash Per Share	6.16	6.23	5.91	4.51	2.99	1.58
Filing Date Shares Outstanding	71.63	68.82	68.82	68.82	68.82	68.82
Total Common Shares Outstanding	71.63	68.82	68.82	68.82	68.82	68.82
Working Capital	371.55	427.64	326.14	233.6	140.95	127.22
Book Value Per Share	12.24	13.49	12.11	11.09	10.04	9.93
Tangible Book Value	744.11	795.34	700.21	629.34	556.16	547.95
Tangible Book Value Per Share	10.39	11.56	10.17	9.15	8.08	7.96
Land	-	148.59	148.59	148.59	148.59	148.59
Buildings	-	233.86	233.58	233.58	233.08	233.39
Machinery	-	49.5	50.77	52.08	55.06	55.32
Construction In Progress	-	2.59	2.39	-	-	-
Leasehold Improvements	-	5.33	5.33	5.33	5.33	5.33

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error